Published in Mol Syst Biol on June 21, 2011
Treatment With Tamoxifen in Cryptococcal Meningitis | NCT03112031
Differential network biology. Mol Syst Biol (2012) 3.74
Antifungal drug discovery: something old and something new. PLoS Pathog (2012) 1.34
The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob Agents Chemother (2012) 1.32
Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med (2014) 1.31
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect Dis (2016) 1.22
Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. MBio (2014) 1.07
Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. PLoS Genet (2013) 0.97
A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryot Cell (2012) 0.94
Targeting the adaptability of heterogeneous aneuploids. Cell (2015) 0.93
The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Antimicrob Agents Chemother (2011) 0.90
Antifungal drug discovery: the process and outcomes. Future Microbiol (2014) 0.86
A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans. Mol Microbiol (2012) 0.85
Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets. Eukaryot Cell (2015) 0.85
A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance. Cell Chem Biol (2016) 0.84
MolClass: a web portal to interrogate diverse small molecule screen datasets with different computational models. Bioinformatics (2012) 0.83
Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds. J Am Med Inform Assoc (2013) 0.83
Comparative interaction networks: bridging genotype to phenotype. Adv Exp Med Biol (2012) 0.83
Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother (2012) 0.83
An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens. Cell Rep (2015) 0.81
Combinatorial strategies for combating invasive fungal infections. Virulence (2016) 0.80
The effect of antibacterial and non-antibacterial compounds alone or associated with antifugals upon fungi. Front Microbiol (2015) 0.79
Antifungal adjuvants: Preserving and extending the antifungal arsenal. Virulence (2016) 0.79
Antagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans. Antimicrob Agents Chemother (2015) 0.79
Regulation of the histone deacetylase Hst3 by cyclin-dependent kinases and the ubiquitin ligase SCFCdc4. J Biol Chem (2014) 0.78
Myriocin significantly increases the mortality of a non-mammalian model host during Candida pathogenesis. PLoS One (2013) 0.78
Target-independent prediction of drug synergies using only drug lipophilicity. J Chem Inf Model (2014) 0.78
Exploring the molecular basis of antifungal synergies using genome-wide approaches. Front Microbiol (2012) 0.78
Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifen. PLoS One (2015) 0.77
Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms. Antimicrob Agents Chemother (2014) 0.77
Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans. ChemMedChem (2015) 0.77
The antifungal pipeline: a reality check. Nat Rev Drug Discov (2017) 0.77
Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection. Eur J Clin Microbiol Infect Dis (2013) 0.76
Synergistic antifungal activity of berberine derivative B-7b and fluconazole. PLoS One (2015) 0.76
Transcriptome and network analyses in Saccharomyces cerevisiae reveal that amphotericin B and lactoferrin synergy disrupt metal homeostasis and stress response. Sci Rep (2017) 0.75
Selection of higher order regression models in the analysis of multi-factorial transcription data. PLoS One (2014) 0.75
Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans. Sci Rep (2016) 0.75
Searching for synergies: matrix algebraic approaches for efficient pair screening. PLoS One (2013) 0.75
Potent Antifungal Synergy of Phthalazinone and Isoquinolones with Azoles Against Candida albicans. ACS Med Chem Lett (2017) 0.75
In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. PLoS One (2016) 0.75
Systematic chemical-genetic and chemical-chemical interaction datasets for prediction of compound synergism. Sci Data (2016) 0.75
The Monoterpene Carvacrol Generates Endoplasmic Reticulum Stress in the Pathogenic Fungus Candida albicans. Antimicrob Agents Chemother (2015) 0.75
High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance. PLoS Biol (2017) 0.75
Functional analysis of selected deletion mutants in Candida glabrata under hypoxia. 3 Biotech (2017) 0.75
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science (2001) 24.48
The genetic landscape of a cell. Science (2010) 16.52
The BioGRID Interaction Database: 2008 update. Nucleic Acids Res (2007) 11.83
The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science (2008) 8.52
Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol (2008) 8.51
Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A (1974) 7.95
Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother (2003) 7.09
Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol (2003) 5.60
Systematic interpretation of genetic interactions using protein networks. Nat Biotechnol (2005) 5.38
Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet (1999) 5.06
Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell (2004) 4.91
Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect (1996) 4.26
Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell (2006) 4.03
Multicomponent therapeutics for networked systems. Nat Rev Drug Discov (2005) 3.99
Systematic discovery of multicomponent therapeutics. Proc Natl Acad Sci U S A (2003) 3.86
Functional classification of drugs by properties of their pairwise interactions. Nat Genet (2006) 3.75
Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol (2006) 3.63
Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol (2009) 3.49
A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov (2007) 3.22
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun (2005) 3.13
Developmental system drift and flexibility in evolutionary trajectories. Evol Dev (2001) 2.45
Efflux-mediated antifungal drug resistance. Clin Microbiol Rev (2009) 2.44
Chemical combination effects predict connectivity in biological systems. Mol Syst Biol (2007) 2.42
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42
GOlorize: a Cytoscape plug-in for network visualization with Gene Ontology-based layout and coloring. Bioinformatics (2006) 2.37
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A (2009) 2.35
Models from experiments: combinatorial drug perturbations of cancer cells. Mol Syst Biol (2008) 2.33
Genetic basis of individual differences in the response to small-molecule drugs in yeast. Nat Genet (2007) 2.18
Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis (2001) 2.15
Combination chemical genetics. Nat Chem Biol (2008) 1.98
Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog (2009) 1.76
Protein dynamics in drug combinations: a linear superposition of individual-drug responses. Cell (2010) 1.75
Sex and virulence of human pathogenic fungi. Adv Genet (2007) 1.63
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A (2007) 1.62
Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo. J Bacteriol (1994) 1.57
From large networks to small molecules. Curr Opin Chem Biol (2004) 1.45
Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis (2002) 1.43
Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genet (2008) 1.37
Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action. Mol Syst Biol (2010) 1.30
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. Mol Cancer Ther (2009) 1.28
Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans. Antimicrob Agents Chemother (2010) 1.26
Characterization of enzymatic synthesis of sphingolipid long-chain bases in Saccharomyces cerevisiae: mutant strains exhibiting long-chain-base auxotrophy are deficient in serine palmitoyltransferase activity. J Bacteriol (1992) 1.21
Multiple weak hits confuse complex systems: a transcriptional regulatory network as an example. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 1.19
Echinocandins: the newest class of antifungals. Ann Pharmacother (2009) 1.14
Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi. PLoS Pathog (2010) 1.14
Invasive fungal infections: the challenge continues. Drugs (2009) 1.13
Chemogenomic profiling predicts antifungal synergies. Mol Syst Biol (2009) 1.11
Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect. J Antimicrob Chemother (2010) 1.09
Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol (1998) 1.07
Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J Proteome Res (2009) 1.07
Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformans. Biochem Biophys Res Commun (2004) 1.03
The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics (2010) 1.02
Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence. PLoS Pathog (2010) 1.00
Systematic validation and atomic force microscopy of non-covalent short oligonucleotide barcode microarrays. PLoS One (2008) 0.97
Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering. Genome Biol (2010) 0.97
Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care (2009) 0.95
High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias. J Lipid Res (2007) 0.94
A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans. Eukaryot Cell (2009) 0.93
Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin Microbiol Infect (2009) 0.88
Precise gene-dose alleles for chemical genetics. Genetics (2009) 0.86
The host acts as a genetic bottleneck during serial infections: an insect-fungal model system. Curr Genet (2006) 0.82
Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66
BioGRID: a general repository for interaction datasets. Nucleic Acids Res (2006) 22.41
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
The BioGRID Interaction Database: 2008 update. Nucleic Acids Res (2007) 11.83
The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science (2008) 8.52
The BioGRID Interaction Database: 2011 update. Nucleic Acids Res (2010) 8.46
The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol (2007) 8.24
Broadening the horizon--level 2.5 of the HUPO-PSI format for molecular interactions. BMC Biol (2007) 8.03
The physics of optimal decision making: a formal analysis of models of performance in two-alternative forced-choice tasks. Psychol Rev (2006) 7.93
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science (2007) 7.61
Global analysis of protein phosphorylation in yeast. Nature (2005) 7.46
Sampling the antibiotic resistome. Science (2006) 7.27
Systematic identification of pathways that couple cell growth and division in yeast. Science (2002) 6.95
The comprehensive antibiotic resistance database. Antimicrob Agents Chemother (2013) 6.41
Osprey: a network visualization system. Genome Biol (2003) 6.23
The BioGRID interaction database: 2013 update. Nucleic Acids Res (2012) 6.09
The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell (2009) 5.96
A global protein kinase and phosphatase interaction network in yeast. Science (2010) 5.95
Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell (2003) 5.72
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res (2005) 5.33
A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev (2004) 5.08
PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat Methods (2011) 5.01
Antibiotic resistance is ancient. Nature (2011) 4.83
How cells coordinate growth and division. Curr Biol (2004) 4.81
A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim Biophys Acta (2004) 4.53
A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway. Cell (2007) 4.21
The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature (2003) 4.18
The GRID: the General Repository for Interaction Datasets. Genome Biol (2003) 4.09
CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast. Cell (2004) 4.04
Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res (2002) 3.68
SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods (2010) 3.50
Stratus not altocumulus: a new view of the yeast protein interaction network. PLoS Biol (2006) 3.44
Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat Methods (2012) 3.17
The Protein-Protein Interaction tasks of BioCreative III: classification/ranking of articles and linking bio-ontology concepts to full text. BMC Bioinformatics (2011) 3.03
Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol (2007) 2.88
Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS One (2012) 2.84
Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination. Cell (2007) 2.69
Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res (2008) 2.62
The size of the nucleus increases as yeast cells grow. Mol Biol Cell (2007) 2.55
Functional genomics and proteomics: charting a multidimensional map of the yeast cell. Trends Cell Biol (2003) 2.46
An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme. Cell (2011) 2.35
Evolutionary and physiological importance of hub proteins. PLoS Comput Biol (2006) 2.34
Structure/function implications in a dynamic complex of the intrinsically disordered Sic1 with the Cdc4 subunit of an SCF ubiquitin ligase. Structure (2010) 2.33
Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors. Mol Cancer Ther (2006) 2.25
ProHits: integrated software for mass spectrometry-based interaction proteomics. Nat Biotechnol (2010) 2.22
Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat Biotechnol (2013) 2.02
Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci U S A (2008) 2.00
Streptogramins, oxazolidinones, and other inhibitors of bacterial protein synthesis. Chem Rev (2005) 1.97
Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol (2005) 1.88
An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase. Nat Biotechnol (2010) 1.88
Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci Transl Med (2014) 1.87
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol (2011) 1.84
Still stratus not altocumulus: further evidence against the date/party hub distinction. PLoS Biol (2007) 1.84
The rate of cell growth is governed by cell cycle stage. Genes Dev (2009) 1.82
The tetracycline resistome. Cell Mol Life Sci (2009) 1.82
High-resolution genetic mapping with ordered arrays of Saccharomyces cerevisiae deletion mutants. Genetics (2002) 1.78
Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation. Mol Cell (2008) 1.78
PhosphoGRID: a database of experimentally verified in vivo protein phosphorylation sites from the budding yeast Saccharomyces cerevisiae. Database (Oxford) (2010) 1.78
Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem Biol (2004) 1.75
Critical issues in bacterial phylogeny. Theor Popul Biol (2002) 1.73
Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Mol Cancer Ther (2010) 1.70
Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat Struct Mol Biol (2008) 1.65
Polyelectrostatic interactions of disordered ligands suggest a physical basis for ultrasensitivity. Proc Natl Acad Sci U S A (2007) 1.65
Biosynthesis of sulfated glycopeptide antibiotics by using the sulfotransferase StaL. Chem Biol (2006) 1.64
Genotype-based changes in serum uric acid affect blood pressure. Kidney Int (2011) 1.62
A cryptic polyene biosynthetic gene cluster in Streptomyces calvus is expressed upon complementation with a functional bldA gene. Chem Biol (2013) 1.59
YjeQ, an essential, conserved, uncharacterized protein from Escherichia coli, is an unusual GTPase with circularly permuted G-motifs and marked burst kinetics. Biochemistry (2002) 1.58
Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proc Natl Acad Sci U S A (2002) 1.57
Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal (2009) 1.54
Expanding the soil antibiotic resistome: exploring environmental diversity. Curr Opin Microbiol (2007) 1.53
Phylogenetics and differentiation of Salmonella Newport lineages by whole genome sequencing. PLoS One (2013) 1.52
A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. Nat Chem Biol (2010) 1.51
Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol Microbiol (2004) 1.50
The dual-specificity phosphatase CDC14B bundles and stabilizes microtubules. Mol Cell Biol (2005) 1.49
Acyldepsipeptide antibiotics induce the formation of a structured axial channel in ClpP: A model for the ClpX/ClpA-bound state of ClpP. Chem Biol (2010) 1.48
ALDH2 mediates 5-nitrofuran activity in multiple species. Chem Biol (2012) 1.48
Problems with co-funding in Canada. Science (2005) 1.48
Bacterial inactivation of the anticancer drug doxorubicin. Chem Biol (2012) 1.46
TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J Biol Chem (2004) 1.45
Chimeric streptogramin-tyrocidine antibiotics that overcome streptogramin resistance. Chem Biol (2005) 1.45
From large networks to small molecules. Curr Opin Chem Biol (2004) 1.45
Recurated protein interaction datasets. Nat Methods (2009) 1.43
Antibiotic adjuvants: multicomponent anti-infective strategies. Expert Rev Mol Med (2011) 1.43
A strategy for modulation of enzymes in the ubiquitin system. Science (2013) 1.43
Kinetic mechanism of the GCN5-related chromosomal aminoglycoside acetyltransferase AAC(6')-Ii from Enterococcus faecium: evidence of dimer subunit cooperativity. Biochemistry (2003) 1.43
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans. Nat Chem Biol (2010) 1.41
Glycopeptide antibiotic resistance. Annu Rev Pharmacol Toxicol (2002) 1.41
Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L. EMBO J (2011) 1.40
CIF-1, a shared subunit of the COP9/signalosome and eukaryotic initiation factor 3 complexes, regulates MEL-26 levels in the Caenorhabditis elegans embryo. Mol Cell Biol (2007) 1.38
Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genet (2008) 1.37